TD-19 has been shown to be effective at inducing apoptosis in non-small cell lung cancer (NSCLC) cell lines at a concentration of 5–10μM46and in mouse testicular cells, CIP2A was significantly down-regulated after treatment with TD-1947. The gene discussed is CIP2A; the disease is non-small cell lung carcinoma.